Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma

Exclusion Criteria

• •Pregnant and lactating women, or women who intend to become pregnant during the study period.
• •Advanced and serious glaucoma, as specified in protocol.
• •Complicated chronic or recurrent uveitis, scleritis or corneal herpes.
• •History of ocular trauma, intraocular surgery or laser surgery for the included eye.
• •Ocular-infection and severe ocular complication.
• •Best-corrected visual acuity (BCVA) worse than 0.2 decimal.
• •Difficulty in conducting applanation tonometry for the included eye as determined by the doctor.
• •Severe or serious hypersensitivity to prostaglandin analogues or any ingredients used in the study.
• •Use of IOP lowering ophthalmic solutions other than TRAVATAN Z® or oral carbonic anhydrase inhibitor (Diamox, etc.) during the study period.
• •Use of any adrenocorticosteroids during the study period.
• •Use of IOP lowering ophthalmic solution within the past 30 days.
• •Regarded by doctor as not suitable for study participation.